3844 J . Org. Chem., Vol. 65, No. 12, 2000
Perch et al.
(d, J ) 5.3 Hz, 1 H), 8.25 (t, J ) 0.9 Hz, 1 H), 8.05 (dd, J )
1.5, 5.3 Hz, 1 H), 4.70 (m, 2 H), 4.47 (dd, J ) 7.9, 9.1 Hz, 1 H),
4.33 (m, 1 H), 4.14 (m, 2 H), 2.29 (m, 1 H), 1.83 (m, 1 H), 1.01
(d, J ) 6.8 Hz, 3 H), 1.00 (s, 3 H), 0.94 (d, J ) 7.0 Hz, 3 H),
0.92 (d, J ) 6.7 Hz, 3 H), 0.80 (d, J ) 6.9 Hz, 3 H). 13C{1H}
NMR (100 MHz): δ 168.2, 160.1, 150.1, 143.1, 138.1, 127.1,
122.5, 73.5, 71.7, 71.5, 68.1, 33.0, 29.7, 19.1, 19.0, 18.5, 14.2,
-8.6. Anal. Calcd (found) for C18H26N3O2PdCl: H, 5.72 (5.72);
C, 47.18 (47.12); N, 9.17 (9.08).
R -5b
[(R)-4-Cycloh exyl-2-(2-p yr id in yl)-2-oxa zolin e]P d (Me)-
Cl (R-5c). Pale yellow solid. 1H NMR (400 MHz): δ 9.03 (ddd,
J ) 0.9, 1.7, 5.0 Hz, 1 H), 7.93 (dt, J ) 1.7, 7.7 Hz, 1 H), 7.71
(dt, J ) 1.0, 7.7 Hz, 1 H), 7.63 (ddd, J ) 1.3, 5.0, 7.7 Hz, 1 H),
4.76 (dd, J ) 4.8, 9.2 Hz, 1 H), 4.63 (t, J ) 9.4 Hz, 1 H), 4.26
(m, 1 H), 1.98-1.87 (m, 1 H), 1.81-0.83 (m, 10 H), 0.99 (s, 3
H). 13C{1H} NMR (100 MHz): δ 168.3, 149.7, 142.9, 138.7,
128.9, 123.8, 72.4, 67.6, 39.8, 29.6, 26.4, 26.3, 25.6, 24.7, -8.9.
Anal. Calcd (found) for C14H21N2OPdCl: H, 5.47 (5.42); C, 46.53
(46.44); N, 7.23 (7.13).
[(R)-4-Isop r op yl-2-isoq u in olin yl-2-oxa zolin e]P d (Me)-
1
Cl (R-5l). Bright yellow powder. H NMR (400 MHz): δ 9.10
(d, J ) 5.8 Hz, 1 H), 8.87 (d, J ) 8.5 Hz, 1 H), 7.99 (d, J ) 5.8
Hz, 1 H), 7.93 (d, J ) 7.9 Hz, 1 H), 7.78 (m, 2 H), 4.87 (m, 2
H), 4.40 (ddd, J ) 3.3, 5.2, 9.4 Hz, 1 H), 2.38 (m, 1 H), 1.05
(s,3 H), 1.00 (d, J ) 7.1 Hz, 3 H), 0.84 (d, J ) 6.9 Hz, 3). 13C-
{1H} NMR (100 MHz): δ 170.1, 141.5, 141.4, 137.5, 131.9,
130.2, 127.9, 126.9, 125.6, 70.0, 67.0, 29.8, 19.0, 14.3, -8.1.
Anal. Calcd (found) for C16H19N2OPdCl: H, 4.82 (4.68); C, 48.38
(48.00); N, 7.05 (6.78).
[(R)-4-P h en yl-2-(2-p yr id in yl)-2-oxa zolin e]P d (Me)Cl(R-
5d ). H NMR (400 MHz): δ 8.99 (d, J ) 4.7 Hz, 1 H), 7.96 (t,
1
J ) 7.7 Hz, 1 H), 7.81 (d, J ) 7.7 Hz, 1 H), 7.64 (br t, J ) 6.2
Hz, 1 H), 7.29 (m, 5 H), 5.48 (dd, J ) 6.7, 10.8 Hz, 1 H), 5.21
(dd, J ) 10.2, 10.8 Hz, 1 H), 4.64 (dd, J ) 7.0, 9.7 Hz, 1 H),
0.63 (s, 3 H). 13C{1H} NMR (100 MHz): δ 169.7, 149.8, 142,8,
139.2, 138.7, 129.3, 129.2, 129.0, 126.8, 124.1, 79.4, 67.0, -7.9.
[(S)-4-Meth ylm er ca p tom eth yl-2-(2-p yr id in yl)-2-oxa zo-
Gen er a l P r oced u r e for Cycliza t ion /Hyd r osilyla t ion .
Methylene chloride (10 mL) was added via syringe to a mixture
of the diene (0.60 mmol), (N-N)PdMeCl (7 mg, 2.2 × 10-3
mmol) and NaB[3,5-C6H3(CF3)2]4 (24 mg, 2.3 × 10-3 mmol) at
-20 °C. Silane (300 µL) was added via syringe and the
resulting solution was stirred at -18 °C for 12 h. Solvent and
excess silane were evaporated under vacuum, and the oily
residue was chromatographed on silica gel to give the car-
bocycle as a colorless oil. Carbocycles which possessed carbo-
tert-butoxy groups (Table 5, entries 1 and 2) were isolated as
the corresponding carbomethoxy derivatives employing the
following procedure: A solution of the crude di-tert-butoxy
carbocycle (∼0.40 mmol) and H2SO4 (10 drops) in MeOH (5
mL) was heated at 60 °C for 12 h. Ether (10 mL) and aqueous
NaHCO3 (10 mL) were added, the layers were separated, and
the aqueous layer was extracted with ether (2 × 10 mL). The
combined organic layers were dried and evaporated under
vacuum, and the residue was chromatographed (hexane:EtOAc
) 24:1) to give the pure dicarbomethoxy carbocycle.
Dim eth yl tr a n s-4-Meth yl-3-[(d im eth yleth ylsilyl)m eth -
yl]cyclop en ta n e-1,1-d ica r boxyla te (7). 1H NMR: δ 3.66 (s,
6 H), 2.52 (dd, 1 H, J ) 6.6, 13.5), 2.46 (dd, 1 H, J ) 6.6, 13.5),
1.61 (dd, 2 H, J ) 10.8, 12.9), 1.39 (m, 2 H), 0.90 (d, J ) 6.0,
3 H), 0.87 (t, J ) 7.8 Hz, 3 H), 0.82 (dd, J ) 2.1, 14.4, Hz, 1
H), 0.44 (q, J ) 7.8 Hz, 2 H), 0.23 (dd, J ) 10.8, 14.4 Hz, 1 H),
-0.06 (s, 6 H). 13C{1H} NMR: δ 172.7, 57.4, 51.9, 51.8, 42.9,
42.8, 42.1, 41.4, 17.7, 16.5, 6.7, 6.6, -3.7, -3.9. IR (neat, cm-1):
1738 (CdO). HRMS (CI) calcd (found) for C15H29SiO4 (MH+):
301.1835 (301.1848).
Diben zyl tr a n s-4-Meth yl-3-(tr ieth ylsilylm eth yl)cyclo-
p en ta n e-1,1-d ica r boxyla te (20). 1H NMR: δ 7.30-7.22 (m,
10 H), 5.08 (m, 4 H), 2.58 (dd, J ) 6.8, 13.4 Hz, 1 H), 2.50 (dd,
J ) 7.0, 13.6 Hz, 1 H), 1.69 (ddd, J ) 6.6, 10.7, 13.4 Hz, 2 H),
1.45 (m 2 H), 0.93 (d, J ) 6.2 Hz, 3 H), 0.89 (t, J ) 7.8 Hz, 9
H), 0.47 (q, J ) 7.8 Hz, 6 H), 0.24 (dd, J ) 11.0 Hz, 14.6 Hz,
1 H). 13C{1H} NMR: δ 172.8, 135.9, 128.7, 128.4, 128.2, 128.1,
67.2, 58.6, 44.0, 43.5, 43.1, 42.3, 17.5, 14.9, 7.7, 4.0. Anal. Calcd
(found) for C29H40SiO4: H, 8.39 (8.56); C, 72.46 (72.44).
Diisop r op yl tr a n s-4-Meth yl-3-(tr ieth ylsilylm eth yl)cy-
clop en ta n e-1,1-d ica r boxyla te (21). 1H NMR: δ 5.13 (septet,
J ) 6.2 Hz, 1 H), 5.12 (septet, J ) 6.2 Hz, 1 H), 2.64 (dd, J )
6.7, 13.3 Hz, 1 H), 2.55 (dd, J ) 6.7, 13.2 Hz, 1 H), 1.74 (ddd,
J ) 6.0, 10.7, 13.3 Hz, 2 H), 1.60-1.48 (m, 2 H), 1.32 (d, J )
6.2 Hz, 12 H), 1.07 (d, J ) 5.1 Hz, 3 H), 1.04 (t, J ) 7.9 Hz, 9
H), 0.97 (dd, J ) 2.2, 11.4 Hz, 1 H), 0.63 (q, J ) 7.9 Hz, 6 H),
0.39 (dd, J ) 11.0, 14.6 Hz, 1 H). 13C{1H} NMR: δ 172.7, 68.6,
58.5, 43.9, 43.4, 43.0, 42.1, 21.7, 17.5, 14.9, 7.6, 4.0. Anal. Calcd
(found) for C21H40SiO4: H, 10.48 (10.39); C, 66.58 (66.42).
1,1-Bis(b en zyloxylm et h yl)-4-m et h yl-3-(t r iet h ylsilyl-
m eth yl)cyclop en ta n e (23). 1H NMR: δ 7.30 (m, 10 H), 4.50
(m, 4 H), 3.30 (m, 4 H), 1.85 (dd, J ) 6.5, 12.9 Hz, 1 H), 1.76
(dd, J ) 6.7, 13.2 Hz, 1 H), 1.2-1.1 (m, 2 H), 0.91 (t, J ) 8.0
Hz, 9 H), 0.90 (d, J ) 5.4 Hz, 3 H), 0.45 (q, J ) 8.0 Hz, 6 H),
0.18 (dd, J ) 10.9, 14.5 Hz, 1 H). 13C{1H} NMR: δ 139.3, 128.5,
127.6, 127.5, 75.7, 73.3, 45.6, 43.6, 43.1, 42.4, 41.6, 18.0, 15.3,
7.8, 4.2. HRMS (CI) calcd (found) for C29H44SiO2 (M+): 452.3111
(452.3127).
1
lin e]P d (Me)Cl (S-5e). Yellow powder. H NMR (400 MHz):
δ 9.02 (br d, J ) 4.1 Hz, 1 H), 7.96 (dt, J ) 1.4, 7.9 Hz, 1 H),
7.78 (d, J ) 7.7 Hz, 1 H), 7.66 (br s, 1 H), 4.87 (br s, 2 H), 4.59
(br s, 1 H), 2.98 (b, 1 H), 2.63 (br s, 1 H), 2.24 (br s, 3 H), 0.96
(s, 3 H). 13C NMR was not obtained due to excessive broaden-
ing of the resonances which was also observed in the H NMR
spectrum. Anal. Calcd (found) for C11H15N2OSPdCl: H, 4.14
(4.30); C, 36.18 (36.27).
1
[(S)-4-(2-Isobu tyl)-2-(2-p yr id in yl)-2-oxa zolin e]P d (Me)-
Cl (S-5f). Yellow powder. 1H NMR (400 MHz): δ 8.95 (m, 1
H), 7.93 (m, 1 H), 7.71 (m, 1 H), 7.61 (m, 1 H), 4.87 (m, 1 H),
4.60 (m, 1 H), 4.35 (m, 1 H), 1.81 (m, 1 H), 1.64 (m, 1 H), 1.41
(m, 1 H), 0.95 (d, J ) 3.0 Hz, 6 H), 0.94 (s, 3 H). 13C{1H} NMR
(100 MHz): δ 167.5, 148.8, 142.1, 137.8, 128.0, 122.8, 61.2,
43.0, 24.7, 22.9, 20.8, -9.6. Anal. Calcd (found) for C13H19N2-
OPdCl: H, 5.30 (5.40); C, 43.23 (43.33).
[(S)-4-Cycloh exylm eth yl-2-(2-p yr id in yl)-2-oxa zolin e]-
P d (Me)Cl (S-5g). Yellow powder. 1H NMR (400 MHz): δ 9.00
(dd, J ) 0.3, 4.6 Hz, 1 H), 7.93 (dt, J 1.6, 7.7 Hz, 1 H), 7.71 (d,
J ) 7.3 Hz, 1 H), 7.61 (ddd, J ) 1.2, 5.1, 7.7 Hz, 1 H), 4.81 (t,
J ) 8.9 Hz, 1 H), 4.59 (dd, J ) 5.0, 8.7 Hz, 1 H), 4.34 (m, 1 H),
1.89 (m, 1 H), 1.77-1.58 (m, 5 H), 1.39-0.85 (m, 7 H), 0.96 (s,
3 H). 13C{1H} NMR (100 MHz): δ 168.3, 149.7, 143.1, 138.7,
128.9, 123.6, 61.6, 42.6, 35.0, 34.4, 32.5, 26.4, 26.1, -8.7. Anal.
Calcd (found) for C16H23N2OPdCl: H, 5.78 (5.83); C, 47.90
(48.14); N, 6.98 (6.91).
[(S,S)-4-sec-Bu tyl-2-(2-p yr id in yl)-2-oxa zolin e]P d (Me)-
Cl (S,S-5h ). Yellow powder. 1H NMR: δ 9.05 (dq, J ) 5.1, 0.9
Hz, 1 H), 7.96 (dt, J ) 7.5, 1.8 Hz, 1 H), 7.73 (d, J ) 7.8 Hz,
1 H), 7.65 (ddd, J ) 1.2, 5.1, 7.8 Hz, 1 H), 4.67 (m, 2 H), 4.44
(ddd, J ) 3.0, 6.0, 9.0 Hz, 1 H), 2.08 (m, 1 H), 1.27 (m, 2 H),
0.99 (s, 3H), 0.97 (t, J ) 7.5 Hz, 3 H), 0.79 (d, J ) 6.9 Hz, 3
H). 13C{1H} NMR: δ 168.5, 149.8, 143.0, 138.8, 129.0, 123.9,
71.8, 66.6, 36.6, 26.6, 12.2, 12.1, -8.9. Anal. Calcd (found) for
C
13H19N2OPdCl: H, 5.30 (5.38), C, 43.23 (43.59); N, 7.76 (7.65).
[(S)-4-ter t-Bu t yl-2-(2-p yr id in yl)-2-oxa zolin e]P d (Me)-
1
Cl (S-5i). H NMR: δ 9.02 (d, J ) 4.8 Hz, 1 H), 8.04 (dt, J )
1.3, 7.6 Hz, 1 H), 7.96 (d, J ) 1.4 Hz, 1 H), 7.64 (ddd, J ) 1.2,
3.8, 7.7 Hz, 1 H), 4.86 (dd, J ) 2.9, 9.4 Hz, 1 H), 4.04 (dd, J )
2.9, 9.0 Hz, 1 H), 1.00 (s, 9 H); 0.97 (s, 3 H). 13C{1H} NMR: δ
149.7, 142.7, 138.5, 128.8, 123.7, 73.2, 70.5, 35.5, 25.7, -5.4.
[(R,R)-4-(Met h oxym et h yl)-5-p h en yl-2-(2-p yr id in yl)-2-
oxa zolin e]P d (Me)Cl (R,R-5j). Yellow powder. 1H NMR (400
MHz): δ 9.07 (br d, J ) 6.0 Hz, 1 H), 7.96 (dt, J ) 1.5, 7.9 Hz,
1 H), 7.81 (br d, J ) 7.7 Hz, 1 H), 7.67 (ddd, J ) 1.4, 5.1, 8.3
Hz, 1 H), 7.40 (m, 3 H), 7.30 (m, 2 H), 5.97 (d, J ) 5.3 Hz, 1
H), 4.35 (m, 1 H), 3.69 (m, 2 H), 3.43 (s, 3 H), 0.95 (s, 3 H).
13C{1H} NMR (100 MHz): δ 169.1, 149.9, 142.8 138.8, 137.8,
129.9, 129.5, 129.3, 126.1, 124.1, 87.9, 87.8, 72.2, 70.7, 70.6,
59.5, -9.2.
{2,4-Bis[2-((R)-4-isop r op yl-2-oxa zolin yl)]p yr id in e}P d -
(Me)Cl (R,R-5k ). Yellow powder. 1H NMR (400 MHz): δ 9.08